Models

Submission ID Name Format Submitter Submitted Modified Sort Descending Certification
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000238 Population PK model for gentamicin Original code Eva Germovsek 2017/03/28 2017/03/28 uncertified model
DDMODEL00000237 Zurlinden_2016_Population_PBPK_model_for_acetaminophen Original code Nan-Hung Hsieh 2017/03/27 2017/03/29 uncertified model
DDMODEL00000240 The Multistate Tuberculosis Pharmacometric model Original code Oskar Clewe 2017/05/10 2017/05/10 uncertified model
DDMODEL00000239 Daily and aggregated seizure counts model for scaling from adults to children in epilepsy Original code Rik Schoemaker 2017/05/03 2017/05/15 uncertified model
DDMODEL00000227 Glucose kinetics in humans: a unique model for different tests PharmML 0.8.x Roberto Bizzotto 2016/10/14 2017/06/30 uncertified model
DDMODEL00000243 Time to event modelling of competing risks Original code Joachim Grevel 2017/07/12 2017/07/19 uncertified model
DDMODEL00000244 Non-linear saturable pharmacokinetic model for high dose rifampicin in tuberculosis patients Original code Robin Svensson 2017/08/11 2017/08/11 uncertified model
DDMODEL00000245 Population Pharmacokinetic Modelling and Estimation of Dosing Strategy for NXY-059, a Nitrone Being Developed for Stroke Original code Agneta Ekholm 2017/08/23 2017/08/24 uncertified model
DDMODEL00000248 Morphine PK in children younger than three years Original code Catherijne Knibbe 2017/09/08 2017/10/09 uncertified model
Showing 101 to 110 of 151 models
First Previous 12 13 14 15 16 Next Last
 
Help